Nationality
US
Year of Birth
1977
1999
Microbiology at Miami University in Oxford, Ohio, B.A.
2006
Business Administration at University of California, San Diego, MBA
2002–2008
Roche Diagnostics, Various Account / Product Manager Roles
2008–2010
Japan / APAC, Tokyo, Commercial Operations Manager
2010–2012
Taiwan, Taipei City, Director Applied Science / Director Molecular Diagnostics
2012–2014
Roche Diagnostics Ireland, Dublin, Country Manager
2014–2016
Roche Pharmaceuticals Peru, Lima, President / General Manager
2016–2018
Roche Pharmaceuticals Korea, Seoul, President / General Manager
2018–2019
Genentech, USA, Vice President, Lifecycle Leader Tecentriq Lung and Head and Neck Cancers
2019
Gilead Sciences, Foster City, USA, Senior Vice-President, Head of Global Commercial Product Strategy
2019–2022
Roche Diagnostics Corporation North America, Indianapolis, USA, President & CEO
Since 2023
Roche Diagnostics Basel, CEO, Member of the Corporate Executive Committee
–
–
Since 2019
AdvaMed, Board Member
–